C1QTNF12 and coronary artery disorder: Notably, CTRP12 exhibits unique anti‐inflammatory and anti‐atherogenic activities compared with other CTRP family members, independently inhibiting macrophage activation, reducing vascular smooth muscle cell proliferation, and modulating vascular remodeling‐processes central to CAD progression and ISR [11, 15].